These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9235677)

  • 1. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
    Nygaard HA; Høvding G
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of topical beta-blockers in glaucoma treatment.
    Goldberg I
    Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.
    Han JA; Frishman WH; Wu Sun S; Palmiero PM; Petrillo R
    Cardiol Rev; 2008; 16(2):95-108. PubMed ID: 18281912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.
    Shore JH; Fraunfelder FT; Meyer SM
    J Clin Psychopharmacol; 1987 Aug; 7(4):264-7. PubMed ID: 3624510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects on systemic adverse effects of ocular drugs].
    Uusitalo H; Salminen L
    Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential side effects of timolol therapy in the treatment of glaucoma.
    Zimmerman TJ; Leader BJ; Golob DS
    Ann Ophthalmol; 1981 Jun; 13(6):683-9. PubMed ID: 7020551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contact allergy to beta blockaders in eye drops: cross allergy?].
    Giordano-Labadie F; Lepoittevin JP; Calix I; Bazex J
    Ann Dermatol Venereol; 1997; 124(4):322-4. PubMed ID: 9739938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and topical ophthalmic beta adrenergic blockade.
    Bourgeois JA
    J Am Optom Assoc; 1991 May; 62(5):403-6. PubMed ID: 1687576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contact allergy to eyedrops containing beta-blockers].
    de Groot AC; van Ginkel CJ; Bruynzeel DP; Smeenk G; Conemans JM
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1034-6. PubMed ID: 9623207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
    Tattersall C; Vernon S; Singh R
    Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac safety of ophthalmic timolol.
    Mäenpää J; Pelkonen O
    Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular beta-blockers and systemic effects.
    Fraunfelder FT
    Arch Intern Med; 1986 Jun; 146(6):1073-4. PubMed ID: 2872865
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal respiratory arrest following timolol ophthalmic solution.
    Malnick SD; Gelzer G; Attali M
    MedGenMed; 2001 Mar; 3(2):12. PubMed ID: 11549961
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrioventricular block secondary to topical ophthalmic beta blockers].
    Rubín López JM; Hevía Nava S; Veganzones Bayón A; Barriales Alvarez V
    Rev Esp Cardiol; 1999 Jul; 52(7):532. PubMed ID: 10439680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
    Taniguchi T; Kitazawa Y
    Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.
    Jappe U; Uter W; Menezes de Pádua CA; Herbst RA; Schnuch A
    Acta Derm Venereol; 2006; 86(6):509-14. PubMed ID: 17106597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact dermatitis to topical drugs for glaucoma.
    Holdiness MR
    Am J Contact Dermat; 2001 Dec; 12(4):217-9. PubMed ID: 11753897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.